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ABSTRACT

Intraovarian growth factors play a vital role in influencing the fate of
ovarian follicles. They affect proliferation versus apoptosis of granulosa cells
(GCs), and can influence whether small antral follicles continue their growth or
undergo atresia. Transforming Growth Factor-alpha (TGF), an oocyte-derived
growth factor, is thought to regulate granulosa cell function, yet has been largely
overshadowed by current interest in TGF-beta superfamily members, such as
bone morphogenetic proteins (BMPs) and anti-Mullerian hormone (AMH). In the
current study, effects of TGF on bovine GC proliferation, intracellular signaling
and cytokine-induced apoptosis were evaluated. Briefly, all small antral follicles
(3-5mm) from bovine ovaries were aspirated and the cells were initially plated in
T25 flasks containing DMEM/F12 medium, 10% FBS, and antibioticantimycotic, and incubated at 37 degrees Celsius in 5% CO2 for 3-4 days. Once
confluent, the cells were sub-cultured to 96-, 12- or 6-well plates in serum-free
conditions (insulin 100 ng/mL; transferrin 55 ng/mL; sodium selenite 6.7 pg/mL).
24-hour treatment of bovine GCs with TGF (10 and 100ng/mL) stimulated cell
proliferation compared to control (p<0.05; n = 7 ovary pairs). Cell proliferation
was accompanied by a concomitant increase in mitogen-activated protein kinase
(MAPK) signaling within 2 hours of treatment, as measured by phosphorylated
ERK1/2 expression (p<0.05, n = 3 ovary pairs). These effects were entirely
negated, however, by the MAPK inhibitor, U0126 (10uM, p<0.05). Additionally,
pre-exposure of the bovine GCs to TGFα (100ng/mL) failed to prevent Fas
Ligand (100ng/mL)-induced apoptosis, as determined by caspase 3/7 activity
(P<0.05, n = 7 ovary pairs). Collectively, the results indicate TGF stimulates
proliferation of bovine GCs from small antral follicles via a MAPK/ERKmediated mechanism, but this action alone fails to prevent apoptosis, suggesting
TGF may be incapable of promoting the persistence of follicles during the
process of follicular selection and deviation.
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CHAPTER 1: REVIEW OF LITERATURE
1.1 Bovine Folliculogenesis: Historical Perspectives and Understanding
Bovine folliculogenesis is a physiological process during which ovarian follicles
are recruited in cohorts and grow over the course of the estrous cycle. Each cohort
initially grows synchronously, through the integration of systemic gonadotropins that
initiate the responsiveness of intraovarian cell populations. Specifically, the actions of
hypothalamic gonadotropin releasing hormone (GnRH) and its action on the anterior
pituitary gland to stimulate the production of follicle stimulating hormone (FSH) and
luteinizing hormone (LH) which have direct stimulatory effects on ovarian follicles. As
its name suggests, FSH is responsible for stimulating follicular growth and recruiting
primary follicle cohorts, which begin to grow synchronously and produce estradiol.
Ultimately, these activities result in the selection of a dominant follicle from the cohort,
which then potentially results in ovulation. With the advancement of ultrasonograpy and
molecular techniques, our understanding of the bovine estrous cycle and folliculogenesis
has accelerated immensely. Researchers can now visualize follicular wave patterns in
animals non-invasively and in real-time, which has established the phases of follicular
development, and has connected them to temporal changes in systemic gonadotropins.
Molecular approaches have facilitated characterization of intraovarian mechanisms which
respond to circulating gonadotropins. Collectively, these activities support local ovarian
dynamics in and among the theca and granulosa cells (GCs) of the follicle, as well as the
oocyte itself. Some of the major discoveries contributing to our current understanding of
folliculogenesis in animals are highlighted in the following sections.
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The estrous cycle of cattle has been very well characterized, including the
behavioral, hormonal, and mechanistic aspects associated with ovarian function in cows
and heifers [1]–[6]. In 1960, Erkki Rajakoski characterized the timing of follicular events
in the bovine ovary in great detail through the use of comparative methods and
slaughterhouse specimens [7]. Rajakoski concluded that primordial follicles develop into
antral follicles and then Graafian follicles, and that their growth is influenced by the
mitotic activity of GCs [7]. He also hypothesized the existence of two follicular waves
during the estrous cycle, in which two dominant follicles develop (attaining a diameter of
8-13mm), but the first dominant follicle of the first wave undergoes atresia and the
second dominant follicle of the second wave ovulates [7]. The ovulated follicle forms the
corpus luteum of the next estrous cycle, that then regresses around seventeen days postovulation [7]. Thus, the two-wave hypothesis of follicular growth during folliculogenesis
in cattle was conceived, and it had a profound effect that guided research in this area for
many years to follow. For instance, 20 years later, in 1984, Pierson and Ginther published
observations about bovine ovarian function in which ovarian structures within the cow
were visualized using transrectal ultrasonography [8]. Although the study was primarily
descriptive and did not test an experimental hypothesis, it transformed research in
reproductive physiology by establishing transrectal ultrasonographic techniques to
accurately image follicles within bovine ovaries and sequentially monitor them over the
course of the entire estrous cycle [8]. Using this technique, the authors visualized follicles
as small as 2-3mm, noting that follicles and corpora lutea have distinct echogenic patterns
which make them easily distinguishable and identifiable [8]. The ultrasound data
assimilated in this study also further supported the two-wave hypothesis because the
2

authors noticed that during each estrous cycle, an anovulatory midcycle dominant follicle
is evident [8].
The emergence of ultrasonography was a defining moment for this area of
reproductive physiology research as many investigators began to appreciate the value of
monitoring bovine ovarian follicular dynamics non-invasively and in real-time.
Additionally, ultrasonography has utility to examine follicular dynamics during
pregnancy without harming the fetus, which is something unattainable using
slaughterhouse sample approaches [9]. The knowledge acquired using this tool facilitated
targeted investigations of hypotheses regarding the specific pattern of follicular
emergence and development; including the two wave hypothesis [7] and the hypothesis
that follicular growth and atresia is a continuous process [10], [11]. In 1988, for example,
it was discovered that two, three, and even four wave patterns of follicular development
occur in cattle [12]–[14]. Additionally, these studies were among the first to show that
growth rate of the largest (termed dominant) follicle does not differ among follicular
waves, and that the ovulatory follicle is consistently the dominant follicle on the day of
estrus (standing heat). Measurement of plasma progesterone and LH confirmed that these
two hormones are associated with atresia and the onset of ovulation of the dominant
follicle, respectively [12]. Sirois and Fortune [11] were among the first to track follicles
individually over the course of an estrous cycle, and they reported that three- and even
four-wave patterns of follicular growth were possible. Conversely, Ginther et al. [15] and
Knopf et al. [16] favored the two-wave hypothesis, suggesting that differences in wave
patterns observed among various studies was due to the different cattle populations in
varying geographical regions. Although their assertion did not deny the presence of three
3

wave patterns, it pointed to more complicated impacts of genetic and environmental
influences on folliculogenesis among different herds. At the time of these studies, there
was still considerable debate about the wave hypothesis altogether, as some researchers
suggested that follicular growth occurs in continuous phases [13]. Eventually, a timeline
and characterization of the temporal differences between two and three follicular waves
of development during the estrous cycle emerged [14], which provided great insight
about the diameters of follicles and the size of the corpus luteum throughout the estrous
cycle [14]. Overall, the studies of the 1980s established new terminology, such as
“subordinate” and “dominant” to describe the temporal relationships (size, growth rate)
among the follicles within the cohort or wave as a proxy to predict their ultimate
physiological fate.
The concept of follicular waves in cattle and other mammalian species
predominates to this day, with the general acceptance that the number of waves can vary
among individuals [17]. In light of this, investigative focus shifted toward examining
hormonal regulation and defining the phases of follicular development: recruitment,
selection/deviation, and dominance. Additionally, researchers sought physiologic
mechanisms that dictate subordinate and dominant follicular phenotypes [18], [19]. For
instance, the emergence of a newly recruited follicular cohort, as visualized using
ultrasonography, occurs 1-2 days following the peak of an FSH surge [20], [21].
Cauterization of the first dominant follicle of the first wave 3 days post ovulation relieves
the suppression of FSH concentrations, which delays regression of subordinate follicles
and hastens recruitment of the next follicular cohort [20]. These concepts highlight the
fact that the dominant follicle (of any wave) is responsible for inhibiting subsequent rises
4

of FSH [14], and this effect is due to its increased secretion of estradiol and inhibin [22],
which ultimately inhibit pituitary FSH through negative feedback mechanisms [23], [24].
The ability of the dominant follicle to diverge and become self-sustaining in its
growth has been coined “follicle deviation”. Follicle deviation has since been adopted to
encompass the dynamics involved in selection of follicles during folliculogenesis.
Interestingly, if the dominant follicle is experimentally ablated, the second largest follicle
of the wave continues its growth and becomes the new dominant follicle of the cohort
[25]. Moreover, any follicle of the cohort that is 5 mm or larger has the potential to
become the dominant follicle [26]. Mechanistically, follicular deviation occurs in tandem
with the establishment of basal concentrations of FSH following the FSH surge [27].
Particularly, lower concentration of FSH encourage and maintain granulosa cell
proliferation and production of estradiol by the dominant follicle, whereas higher
concentrations impair cell division and stimulate progesterone production [28]. Thus,
growth of the dominant follicle requires diminishing concentrations of FSH as it
approaches maturity [29]. The importance of relative size of the follicle in establishing its
dominance is further underscored by the observation that both LH and FSH receptor
expression remains relatively unchanged during selection of the dominant follicle [30],
despite the waning concentrations of available gonadotropins. Follicular dominance is
generally established at ≥8.5 mm, within an 8 hour window, and only once the follicle
secretes sufficient amounts of inhibin to impair further FSH secretion [25], [31]. As the
dominant follicle matures to become pre-ovulatory, it switches from FSH- to LHresponsive [32].
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In recent years, research focus in folliculogenesis has shifted from the temporal
and hormonal regulation at the systemic level to mechanisms that regulate intraovarian
dynamics, specifically intracellular signal transduction pathways that influence cell fate.
Many types of signaling molecules exist in the follicular fluid and are secreted by cells of
the ovarian follicle: these include insulin-like growth factor-1 (IGF-1), members of the
transforming growth factor (TGF) - superfamily, fibroblast growth factor (FGF), and
members of the epidermal growth factor (EGF) family ligands [33]. These pathways have
multiple functions within the ovary that invoke cellular activities and influence cell fate
in response to hormonal stimulation. The establishment cell culture methodology to
sustain bovine ovarian cells in vitro [34]–[36] has helped to characterize key intraovarian
factors involved. For instance, through the use of a theca cell culture system,
investigators have found that TGF (an EGF family ligand) increases cellular
proliferation; while TGF stimulates progesterone production in the presence of estradiol
[37]. This suggests an inverse relationship, regulated by TGF signaling, possibly exists to
influence growth and differentiation of follicles. Oocyte-secreted factors of the TGF
superfamily, such as bone morphogenetic proteins (BMPs) and growth differentiation
factors (GDFs), protect granulosa cells from apoptosis in cultures of cumulus-oocytecomplexes [38]. Hence, not only do somatic cells contribute to follicular mechanisms, but
the oocyte itself likely has an important regulatory role in determining follicular
dynamics and follicular fate. Initial insight about mechanisms possibly triggering
follicular atresia has also been obtained using granulosa and theca cell culture systems.
For instance, Porter et al. demonstrated that Fas antigen mRNA is expressed in granulosa
cells of follicles, and that granulosa cells of dominant follicles exposed to the LH surge in
6

vivo are resistant to FasL-induced apoptosis [39]. From these observations, Porter et al.
concluded that GCs from subordinate (atretic) follicles are more susceptible to FasLinduced killing than those of healthy dominant follicles, suggesting a fundamental
difference between GCs of the follicular phenotypes, and LH-induced differentiation.
Collectively, contributions such as these have informed current understanding about the
regulation of bovine folliculogenesis and the potential cellular mechanisms by which
hormones and growth factors mechanistically exert their effects.
Among the more intensely-studied growth factors associated with the bovine
ovary are FGF, EGF and TGF. Bovine granulosa cells express a gene encoding for FGF,
which is hypothesized to develop the vascular system of the theca layer of the follicle
through paracrine actions [40]. In culture, FGF and EGF help maintain the bovine GC
phenotype; whereas absence of these factors causes cells to quickly differentiate and lose
GC characteristics [41], [42]. The effects and interactions of these local growth factors
can be complex, often altering the actions of other growth factors on cultured follicular
cells. For instance, TGF produced by thecal cells inhibits the proliferative effect of EGF
on cultured bovine granulosa cells in a paracrine manner [43]. As the field of growth
factor research expands, growth factors are now classified into family groups based on
similar receptor-ligand interactions. For example, TGF is a member of the EGF family
of ligands. It is expressed in bovine theca cells [44], [45], yet stimulates the proliferation
of both theca and GCs in vitro [45]. The works of Gospodarowicz et al., Skinner et al.,
and others has affirmed the complexity of growth factor interactions and ligand-induced
intracellular mechanisms as they pertain to follicular development [46], [47]. As an
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example, FGF and EGF in combination induce a robust, proliferative response in bovine
granulosa cells; but they have no proliferative effect independently [48].
With a clear, demonstrated presence within the ovarian follicle, growth factors are
plausible local regulators of gonadotropin effects on ovarian cell populations. Among the
various families of growth factors characterized, for instance, TGF and TGF share an
inverse yet complementary relationship that impacts proliferation and steroidogenesis of
bovine thecal cells. TGF increases bovine theca cell proliferation while decreasing
androstenedione production; whereas TGF inhibits proliferation and stimulates
progesterone production [37]. In terms of bovine granulosa cells, IGF-1 increases
estradiol secretion, principally by increasing expression of cytochrome P450 enzymes
that promote aromatase and steroidogenic activity [49]. As insight is gained about the
actions of these various growth factors, focus has shifted towards determining the
signaling pathways that mediate these regulatory actions and determining how these
factors influence follicular fate. Very little is known at this point, however, about how
these mechanisms translate to modulation of bovine follicular dynamics.
During the past 60 years or more in which research of bovine follicular dynamics
has been studied, great advances in technology (e.g., ultrasonography, immunoassays,
and molecular techniques) have led to greater understanding of the growth, maturation,
and death of follicles, ranging from the systemic to the cellular levels. Folliculogenesis is
a process requiring many temporally-orchestrated ovarian events; the majority of which
are regulated both systemically and molecularly. Historical hypotheses and experiments
put forward have clearly defined the follicular phases, providing opportunities for future
8

scientific pursuits, as well as the potential to manipulate and improve fertility. Continued
exploration of these phenomena at the cellular and molecular levels will provide new
insight, and perhaps bring new avenues to benefit agricultural production systems and our
understanding of the ovarian system in other monovulatory species.
1.2 Hormonal Regulation of Follicular Dynamics
The bovine estrous cycle is approximately 21 days in length and is regulated
through the endocrine actions of hypothalamic, anterior pituitary, ovarian, and uterine
secreted hormones [17], [50]. The major endocrine hormones involved in this regulation
are GnRH, FSH, LH, progesterone, and prostaglandin (PGF2). These hormones are
upregulated and down regulated over the course of the estrous cycle in cattle in response
to positive and negative feedback systems. GnRH is produced by the hypothalamus and
stimulates the anterior pituitary to secrete gonadotropins, FSH and LH [51]. Studies first
linking the pituitary gland to the reproductive organs in animals were reported in 1910,
when partial removal of the pituitary gland compromised the gonadal function of dogs.
The gonadal organs of dogs shrank and deteriorated, and the sexual development of
puppies was interrupted [52]. In 1929, Zondek postulated that the secretions of the
pituitary gland stimulate the gonads. He observed the timing of their secretion was
temporally associated with follicular growth and ovulation [53], [54]. These secretions,
originally known as ‘Prolan A’(later FSH) and ‘Prolan B’(later LH), coordinated the
rhythm of ovarian events and regulated endometrial function [53]. FSH and prolactin
were also detected in isolates of the anterior pituitary gland of cattle in 1935 [55].
Whereas these hormones ultimately became a large focus of human medical research and
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infertility treatment in those days, manipulation of their expression to control estrus in
production animals was also viewed as potentially advantageous. Thus, the combined
effort of many researchers over the past 100 years has led to considerable understanding
of the bovine estrous cycle, specifically the behavioral, ovarian, and associated
physiologic hormonal changes of the cycle.
Initially, hormonal concentrations of reproductive molecules were difficult to
study in cattle, but the development and refinement of techniques such as liquid-gas
chromatography and competitive protein binding techniques changed all this.
Researchers extracted hormones from circulating blood plasma, and determined their
relative abundances over the course of the estrous cycle [50], [56]–[58]. Since these
initial observations, the hormonal regulation of bovine folliculogenesis has been well
characterized. As previously stated, folliculogenesis consists of three defined phases of
development that are regulated by these hormonal fluctuations: recruitment,
selection/deviation, and dominance.
Recruitment of ovarian follicles is defined by the emergence of a follicular cohort
from a primordial state. A transient increase in anterior pituitary-derived FSH activates a
new follicular wave by binding to its receptors on GCs of primordial follicles [20], [59],
[60]. Experimentally, injections of GnRH can synchronize FSH surges, which
subsequently stimulate follicular recruitment in cattle [21]. Anti-Müllerian hormone
(AMH) is secreted by GCs of primordial follicles [61] and is a marker that predicts
gonadotropin-responsive primordial follicles [62], [63]. Thus, AMH potentially regulates
follicular recruitment and FSH activation, ensuring that the entire ovarian reserve is not
depleted in one follicular wave. FSH binding to granulosa cells stimulates proliferation
10

and aromatase activity, enabling the cells to synthesize estradiol [64]–[66] and inhibin
[67], [68]. LH binds to receptors on theca cells and stimulates the conversion of
cholesterol to androgen precursors for the granulosa cells to then convert to estradiol.
These relationships establish an important coordination between the theca and granulosa
cells in follicular development [69]–[72]. Estradiol secreted by the developing follicles
asserts a positive feedback mechanism on the hypothalamus to enhance GnRH secretion.
This effect triggers transient rises in FSH and LH, but FSH secretion is later suppressed
by the negative feedback effects of follicular inhibin [28]. As the follicles reach 6 mm in
diameter, a selection event occurs in which one follicle from the cohort continues to grow
and increase in size while the remaining follicles regress and undergo atresia [73].
Ultimately, the largest follicle deviates from its subordinates and continues to grow (i.e.,
becomes dominant), becoming less reliant on FSH stimulation as it produces higher
amounts of estradiol and inhibin [29].
Once the dominant follicle reaches ovulatory stage, its granulosa cells become LH
responsive [74], [75] and estradiol secretion peaks. The estradiol positive feedback on the
hypothalamic-pituitary axis generates a transient surge in LH secretion, which causes the
dominant follicle to ovulate [76]–[78]. Following ovulation, both the theca and GCs of
the ovulatory follicle luteinize to form the corpus luteum and begin to secrete
progesterone [79], [80]. Although the corpus luteum is the dominant structure on the
ovary during this time, follicular waves still emerge throughout the estrous cycle.
However, the high concentrations of circulating progesterone prevents the LH surge
necessary for ovulation [74], [81]. Dominant follicles of waves that emerge during this
period of high progesterone secretion are unable to continue their growth and eventually
11

undergo atresia like their subordinates within the cohort. If fertilization and pregnancy is
not established following ovulation, PGF2 secreted by the uterine endometrium exerts a
luteolytic effect on the corpus luteum, causing tissue regression and the loss of
progesterone production [82], [83].

1.3 Reproductive Challenges Associated with Dairy Cattle
Unique challenges exist in the reproductive management of dairy cattle. In order
for dairy cows to remain productive and economically valuable, they must produce calves
every year in order to meet the demands of profitable milk production. High producing
dairy cattle often experience postpartum anestrus for a number of reasons [84], but the
most notable reason is the partitioning of energy toward lactation rather than reproductive
function [85]. Ideally, dairy cattle should become pregnant in early- to mid-lactation.
However, at this point in time the cows are in negative energy balance metabolically and
have insufficient energy reserves to support fertilization, let alone a fetus [86]. Energy is
partitioned away from ovary function, thus negatively affecting follicular growth,
ovulation, and overall estrous cyclicity [87]. The difficulty of attaining good fertility in
dairy cattle is also complicated by the trend toward increased herd sizes. Many herds in
the U.S. average 500 head or more in the milking group, complicating reproductive
management strategies related to timed artificial insemination (AI) protocols that require
specific and individual attention to detail [88]–[90]. A better understanding of the
mechanisms influencing ovarian cyclicity, particularly at the cellular and molecular level,
may offer insight to improve management strategies and timed AI protocols.

12

1.4 The Bovine Ovarian Follicle
The intraovarian environment of the follicle is composed of somatic cells (e.g.,
theca and GCs) and the oocyte that secrete a large variety of signaling molecules to
coordinate processes during development and maturation. These somatic cells and the
oocyte all have distinctive functions and secrete various autocrine and paracrine
molecules that harmoniously impact the development and maturation of the follicle and
its continued growth or atresia/regression. The two main somatic cell types of the ovarian
follicle are GCs and theca cells. Theca cells are LH responsive and synthesize androgens
for GC conversion to estrogens [69]–[71], [91]. Theca cells are also important in
supporting angiogenesis of the follicle [92], [93] and antrum formation [94]. GCs are by
far the most abundant cell type in the follicle and their proliferation in response to FSH is
necessary for the initial growth of antral follicles (3-5 mm) [11], [95]. As mentioned
above, GCs also have an important role in the conversion of androgens to estradiol in
growing antral follicles [64], [70]. This compartmentalized aspect of steroidogenesis
within the follicle is known as the “two cell, two gonadotropin hypothesis”, where LH
receptors and FSH receptors expressed on theca and GCs, respectively, and respond to
the gonadotropins independently to collectively synthesize estradiol [96], [97]. The initial
growth of primordial follicles is largely characterized by proliferation and formation of
gap junctions between GCs, and the growth of the oocyte [98], [99]. Eventually, the zona
pellucida surrounding the oocyte is formed, and the gap junctions extending from
granulosa cells to the oocyte are formed. The gap junctions help to maintain the oocyte in
meiotic arrest [98]. As the GCs proliferate and the follicle grows, estradiol secretion also
13

increases, exerting a positive feedback effect on the hypothalamus to stimulate GnRH
release, an LH surge, and ultimately ovulation of the dominant follicle [31], [87]. Upon
ovulation, the somatic cells of the follicle differentiate into luteal cells to form the corpus
luteum and synthesize progesterone [80], [100].

1.5 Cellular Mechanisms of Ovarian Follicular Selection
Although the primary regulation of ovarian events is carried out by circulating
gonadotropins and hormones, when it comes to follicular development and maturation in
response to these hormones, local regulation within the microenvironment of individual
follicles is imperative. Intrafollicular dynamics influence follicular growth by stimulating
proliferation of GCs and thecal cells and by protecting the developing oocyte.
Conversely, these same signaling factors can regulate follicular fate by triggering
follicular atresia. Although multiple local signaling factors likely coordinate these
follicular processes and influence follicular fate, IGF-1, through stimulation of
phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) signaling pathway, is widelybelieved to have the greatest impact on follicular fate and survival during follicular
selection and deviation. IGF-1 was first suggested to have a regulatory role in the ovarian
follicle based on its observed ability to stimulate cellular proliferation and differentiation
in a wide variety of cell and tissue types [101]. Indeed, IGF-1 influences secretion of both
progesterone [102] and estradiol [49], [103] by GCs. However, in the presence of LH,
production of estradiol is attenuated [49], which suggests the stimulatory effect of IGF-1
on estradiol production by GCs is only relevant to small follicles [102] (i.e. before the
follicles reach ovulatory stage). IGF-1 stimulates both mitogen activated protein
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kinase/extracellular regulated kinase (MAPK/ERK) and PI3K/Akt signaling in GCs
[104], [105]. However, only its effect on PI3K/Akt activation stimulates GC cell cycle
progression to protect against FasL-induced apoptosis [105]. This observation has been
put forth as a potential survival mechanim for GCs to protect against follicular atresia.
IGF-1 also stimulates GC proliferation [103], [106], which supports an active mitotic
environment for developing follicles. Interestingly, conditional knockdown of the IGF-1
receptor in GCs results in sterility, with an inability to develop antral follicles and a 90%
decrease in estradiol production [107]. Thus, it is clear that IGF-1 plays a vital role in
follicular growth.
Despite the previous assertion that IGF-1 stimulates both MAPK/ERK and
PI3K/Akt signaling, the effect on MAPK is not consistent [49]. Moreover, when present
in high concentrations, IGF-1 makes GCs more prone to apoptosis [49], contradicting the
idea that IGF-1 alone supports follicular survival. Phosphorylated forms of both ERK and
Akt (the downstream targets of MAPK and PI3K signaling, respectively) are upregulated
in follicles destined to become dominant [108]. Both ERK and Akt activation in GC and
theca cells by IGF-1 and gonadotropins stimulate cell growth and steroidogenic function
[109]. Thus, although there is some uncertainty about the relative importance of
MAPK/ERK activation in promoting GC function and follicular survival, it remains
important to identify specific ligands that stimulate this pathway and evaluate their
effects. Importantly, down regulation of ERK signaling is associated with apoptosis of
GCs [110]. The EGF receptor ligands are prominent stimulators of MAPK signaling
activity [111], therefore their effects are worthy of consideration when investigating the
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fates of follicles. For instance, EGF and TGF are hypothesized to prevent apoptotic cell
death of GCs in ovulatory follicles [112].
1.5.1 Epidermal Growth Factor Family of Ligands
During the 1970s, growth factor discovery and classification was prominent;
growth factors regulating cellular activity was a novel concept and researchers strove to
improve cell culture systems through their use [113]–[115]. EGF was one of the first
factors isolated and purified, and is a mitogenic factor in a number of different cells and
tissues [116]. Growth factors of the EGF family of ligands are associated with
tumorigenic activity, stimulating cellular growth and differentiation through receptor
tyrosine kinase (RTK) signaling [117]. EGF family ligands include, but are not limited to,
TGF, heparin-binding EGF, amphiregulin, betacellulin, epiregulin, and epigen [118],
[119]. These factors bind to a common receptor (EGFR), which is an RTK that
heterodimerizes and is activated through autophosphorylation, and stimulates multiple
signaling pathways within cells, including MAPK and PI3K [119]–[121]. MAPK
activation through this receptor requires the recruitment of the Grb2 adaptor protein, and
the formation of a Grb2/Sos complex to activate Ras; whereas PI3K signaling can be
activated directly [122].
The molecule EGF, specifically, influences ovarian signaling and cellular
regulatory mechanisms. For example, EGF stimulates GC proliferation in cells derived
from large follicles, but once the cells luteinize the proliferative response is attenuated
[123]. EGF also regulates steroidogenic functions, including the enhancement of
progesterone production [46], which suggests it augments GC differentiation, possibly
during post-ovulatory processes. In the pig, EGF is present in follicular fluid [124] and
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promotes GC proliferation in vitro [106]. Furthermore, proliferation is synergized when
combinations of TGF and IGF-1 are included in the treatments [106]. However, EGF
was the only growth factor in the study to stimulate proliferation independently. TGF
and IGF-1 failed to stimulate cell number and DNA synthesis [106], further supporting
the concept that IGF-1 alone is insufficient to promote GC growth.
Since its original discovery and characterization in murine cells [125], [126]
TGF continues to be viewed as closely related to EGF, sharing a common membrane
receptor. However, TGF and EGF do not exert the same biological actions [127], and
each has specific and unique functions in cellular activities. May and Shomberg
speculated that TGF and EGF have separate actions in ovarian function, with TGF
being more important in luteal formation due to its ability to stimulate angiogenesis and
wound healing in other tissues [128]. Consistent with the observation that EGF induces
progesterone production, TGF prevents FSH-stimulated aromatase activity in rat
granulosa cells [129]. Conversely, this same study demonstrated an augmentation of
aromatase activity by TGF, and postulated that TGF may be the more influential
transforming growth factor in the regulation of ovarian cyclicity [129]. TGF is localized
to the theca-interstitial cells of rat ovaries [130], and this is consistent with a study of the
bovine ovary [44]. Together, these studies establish TGF is theca-derived. A more
recent study, however, indicates TGF is also present in the oocytes of bovine follicles
[131], which suggests multiple cellular sources of TGF exist in the follicle.
In bovine GCs, TGF inhibits the secretion of estradiol, inhibin A, activin A, and
follistatin both independently and in the presence of FSH and IGF-1 stimulation [131].
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Under these same conditions, TGF also stimulates cellular proliferation [131], which
suggests a modulatory role of TGF during early follicular development. Others report
that TGF prevents spontaneous apoptosis of rat granulosa cells in culture [132]. Thus,
TGF exerts potent proliferative and somewhat protective effects in cultured GCs, which
suggests a possible regulatory role in the selection and/or survival of the dominant
follicle.
1.5.2 Transforming Growth Factor-alpha in the Bovine Ovary
Characterization of TGF in the bovine follicle since the late 1980s and early
1990s is limited [47]. TGF is secreted by bovine theca cells [44], [133] into the
follicular fluid where it can act in a paracrine manner to decrease estradiol production by
GCs from large follicles (>10 mm) [134]. Although it impairs bovine GC
steroidogenesis, TGF also stimulates cell proliferation [37], indicating that it may also
prevent cellular differentiation. TGF stimulates cumulus GC function, which in turn
supports the maintenance of high quality oocytes [135]. No other literature about TGF
in the bovine follicle seemingly exists until the early 2000s, when Glister and colleagues
localized TGF to the bovine oocyte [131], and showed the paracrine action of TGF to
suppress estradiol and inhibin secretion by GCs in response to FSH and IGF-1 [131],
[136]. These authors proposed that TGF mediates the actions of oocytes on GCs.
Additionally, this study initially established the novel and diverse functions of TGF, as
compared to EGF, by showing that EGF is undetectable in the same oocytes [131].
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1.5.3 Mechanisms of Follicular Atresia and Apoptosis
The idea that cell death is an organized and regulated process through apoptotic
signaling was first presented in the 1970s when Kerr et al. summarized evidence from
multiple studies to characterize the process, and established it as a “basic biological
phenomenon” that balances mitosis with cell turnover [137]. The process of programmed
cell death occurs in two phases: the first entails condensation of the nucleus and
cytoplasm, and their subsequent fragmentation into “apoptotic bodies”, the second
consists of phagocytosis of the apoptotic bodies by other surrounding cells. Based upon
the criteria established by Kerr et al., the ovary soon became an attractive model to study
these mechanisms due to its dynamic and constant cellular remodeling, particularly in the
context of ovulation and luteal function. With regard to follicular dynamics, apoptosis is
an extremely important process because the majority of follicles within the ovary fail to
become dominant, and instead undergo atresia [138]. This newly defined apoptotic
phenomenon was characterized in ovine follicles based upon observations of cellular and
nuclear fragmentation, and the subsequent phagocytosis of these fragments [139] [140].
Granulosa cells of the follicle are among the most severely affected.
By the early 1990s, apoptosis became widely accepted as a common process by
which follicular atresia ensued, and that granulosa cells were the main cell type targeted
[112], [138], [141]–[143]. A shift from identifying the cell types undergoing apoptosis
within the follicle to determining the mechanisms of atresia occurred. Several locally
produced cytokines are associated with apoptotic events during follicular atresia. Among
these, tumor necrosis factor- (TNF-) invokes apoptosis in cultured rat antral follicles
and decreases aromatase activity in cultured granulosa cells [144]–[146]. TNF--induced
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effects are mediated through the secondary messenger, ceramide [144]. Fas ligand
(FasL), a member of the TNF family of ligands, is also thought to contribute to follicular
atresia. Its receptor, Fas, is a member of the TNF family of cellular membrane receptors
[147]. Abundant amounts of Fas expression are seen in cells of mouse ovaries [148],
[149], in bovine theca and GCs [39], [150], and in hen GCs [151], particularly during
episodes of follicular atresia. In cultured bovine GCs, FasL-induced apoptosis is
enhanced by serum withdrawal [152], and is modulated by the presence of growth factors
[153]. For these reasons, Fas is commonly considered the mediator of GC apoptosis and
follicular atresia [154].

1.6 Hypotheses, Aims, and Objectives

In the current study, our working hypothesis was that growth factors, through
increases in MAPK/ERK signaling, provide resistance to FasL-induced apoptosis in
bovine GCs during folliculogenesis. Particularly, GCs fundamentally support the early
growth of small ovarian follicles through their proliferation and cellular signaling. This
proliferation is largely supported by the actions of intrafollicular endocrine molecules
which act to stimulate and support GC proliferation, and, ultimately, follicular survival.
The specific objective was to determine if an enhancement of ERK signaling in bovine
GCs provides resistance to Fas-mediated apoptosis as a possible cellular mechanism for
follicle persistence and selection.

The specific aims were to:
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(1) Evaluate the effects of growth factor stimulation on MAPK/ERK signaling
in bovine GCs,
(2) Reproduce the apoptotic effects of FasL on cultured bovine GCs, and
(3) Demonstrate that MAPK/ERK signaling mediates the protective effect of
growth factors on FasL-induced apoptosis
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CHAPTER 2: PRELIMINARY EXPERIMENTS

2.1 Introduction
To investigate the stated objective and aims, it was imperative to first survey and
profile which growth factors stimulate bovine GCs in our unique, serum-free culture
system established in the Townson laboratory. Many of the previous growth factor
studies reported in the literature utilized culture systems in which GCs are isolated from
follicles, pooled together from several animals, and then treated with growth factors in
which the culture medium contains varying amounts of fetal bovine serum (FBS). In cell
culture systems, FBS is utilized to support successful cellular growth, differentiation and
maintenance in in vitro environments and has been used to promote cellular adhesion of
GCs to culture flasks following isolation [155], [156]. Without question, FBS inherently
contains of variety biomolecules and cell growth promoting constituents at undefined
concentrations, which could confound effects of added growth factors. Conversely, in our
culture model, the cells are maintained in a serum-free system in which the constituents
of the culture medium are defined, and the effects of growth factors can be individually
or collectively evaluated. Additionally, the cultures of GCs are established using ovary
pairs collected from an individual cow (i.e., the cow is the experimental unit) to avoid
any confounding effects attributable to pooling of cells from several animals. For these
reasons, the preliminary experiments described herein were intended to evaluate the
effects of several growth factors individually and collectively to ensure that any
stimulatory effects were consistent with those previously reported in the literature.
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Additionally, the purpose of this screening was to identify particular growth factors that
induced a proliferative response mediated by MAPK/ERK stimulation.
2.2 Materials and Methods
2.2.1 Review of Literature
A review of the literature, summarized above, was completed to gain
understanding and an introductory perspective about the various growth factors that exist
and that potentially impact the ovarian follicular microenvironment. The growth factors
that were identified as plausible candidates for the thesis work, and that were further
discussed among the thesis committee members for further profiling were FGF, EGF,
TGF , TGF, and IGF-1. These growth factors were then tested in dose-response and
time-course experiments to evaluate their efficacy in stimulating bovine GC proliferation,
and as a lead-in to examining growth factor-induced MAPK/ERK signaling.
2.2.2 Cell Culture and Reagents
Pairs of bovine ovaries were obtained from Champlain Beef (Whitehall, NY) and
transported to the laboratory in 0.9% NaCl solution supplemented with antibioticantimycotic at room temperature. All ovaries were collected and processed within 4-5
hours of slaughter. All small (3-5mm) antral follicles were aspirated to obtain bovine
GCs. Small (3-5mm) follicles were selected due to follicular dominance not being
achieved until a follicle has reached a diameter of 8-10mm, indicating that granulosa and
follicular fate would not be decided at a small follicular size. The GCs obtained from
each ovary pair were kept separate, rather than pooled, for the culture experiments.
Hence, a given culture consisted of cells obtained from a single pair of ovaries, making
an individual cow the experimental unit (n = 3). The retrieved cells were pelleted,
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resuspended, and seeded into individual T25 flasks. Cells were cultured in Dulbecco’s
Modified Eagle Medium/Ham’s F12 Nutrient Mixture (DMEM/F12) medium initially
containing 10% FBS and antibiotic-antimycotic (complete culture medium) and
incubated in a humidified incubator at 37C with 5% CO2 until the cultures reached
confluency (~3-4 days). Once confluent, the cells were passaged, enumerated, and
subsequently seeded into culture vessels for further testing. The day after seeding, the
cultures were switched to serum-free DMEM/F12 medium supplemented with insulintransferrin-selenium (ITS) (10 ng/ml insulin, 5.5 ng/ml transferrin, 0.67 pg/ml sodium
selenite), without or with specific concentrations of growth factors. The growth factors
tested were recombinant human epidermal growth factor (EGF; Gibco), recombinant
human transforming growth factor-1 (TGF; R&D Systems), recombinant human
transforming growth factor- (TGF; R&D Systems), and human insulin-like growth
factor-I (IGF-1; Cell Signaling Technology). The growth factors selected were
determined based on materials used throughout previous studies reported in the literature.

2.2.3 Growth Factor Effects on Cellular Proliferation
Bovine GCs were seeded into clear-walled, 96-well plates (5,000 cells/well for
individual growth factor tests and 10,000 cells/well for combined growth factor tests)
using complete culture medium. The following day, the cells were switched to serum-free
medium containing individual or combined concentrations of the growth factors (0, 1, 10,
and 100 ng/mL) and incubated for 24 or 48 hours. Complete culture medium (containing
FBS) was used as the positive control for proliferation, and staurosporine (a
chemotherapeutic agent that induces apoptosis) was used as the negative control and
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successfully abolished any proliferative effect of all treatments and killed the cells,
detected both observationally and by no detectable level of MTS absorbance (data not
shown). Following the time of treatment, relative proliferation of bovine GCs was
assessed using an MTS assay (CellTiter 96 AQueous One Solution Cell Proliferation
Assay, Promega) in which the absorbance at 490 nm was measured and recorded using a
BioTek Synergy HT plate reader (BioTek).
2.2.4 Growth Factor Effects on Cellular Proliferation
All experiments were conducted using a minimum of three biological replicates
from an independent pair of ovaries (i.e., cow is the experimental unit). Data were
analyzed by one-way analysis of variance (ANOVA), followed by a Student’s T-Test.
Differences among means were considered significant at p<0.05.
2.3 Results
2.3.1 Effects of Individual Growth Factors on Bovine Granulosa Cell Proliferation

Figure 1. MTS Assay analysis of bovine granulosa cell proliferation in response to growth factor
treatment (TGF, TGF, IGF-1, and EGF). Bars represent means of recorded absorbance values at
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490 nm  SEM (n = 3 ovary pairs) for bovine granulosa cells exposed to different concentrations of
each growth factor (0, 1, 10, or 100 ng/mL) for 24 hours . The same absorbance value patterns were
seen after 48 hours of treatment, with the recorded values raised slightly.

All growth factors examined suggested an induced a proliferative response in
comparison to control treatment (Figure 1). No statistical difference among treatments or
doses was identified, but this was most likely attributed to the low number of ovary pairs
utilized for the experiments. Among the 4 growth factors tested, TGF was qualitatively
the most potent, reaching a maximal response at 10 ng/mL (Figure 1). TGF and EGF
were the least potent qualitatively (Figure 1), with EGF being the only growth factor to
suggest a dose-dependent trend. Effects of IGF-1 treatment were intermediate to TGF
and the other growth factors (Figure 1). Following 48 hours of treatment, the same
proliferation trend was observed, and all treatments showed a similar amount of increase
in absorbance values (data not reported).
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2.3.2 Combined Growth Factor Effects on Bovine Granulosa Cell Proliferation

Figure 2. MTS Assay analysis of bovine granulosa cell proliferation in response to growth factor
treatment combinations including TGF. Bars represent means of recorded absorbance values at
490 nm  SEM (n = 3) for bovine granulosa cells exposed to a 10 ng/mL concentration of each growth
factor combination for 24 hours.

All possible treatment combinations of the growth factors were evaluated at
multiple doses (0, 1, 10, and 100 ng/mL). However, for ease of interpretation, only the
growth factor combinations that included TGF at the 10 ng/mL dose are depicted here.
Overall, and unexpectedly, the proliferative responses here were not as robust as in
previous experiments (Compare Figures 1 and 2). This was attributed to higher seeding
densities (10,000 cells/well) established in these experiments, which presumably
predisposed the cells to premature contact inhibition. Nevertheless, TGF, when
combined with either TGF or IGF-1, somewhat augmented the proliferative response,
but overall there were no statistical differences among the various treatment groups
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2.4 Discussion
Based upon the observed effects of growth factor stimulation on bovine GC
proliferation, TGF was selected as the candidate stimulator of proliferation among the
four growth factors tested. Seeding methods between the two experiments (individual and
combined growth factor experiments) differed and were inconsistent because the
investigator had not yet developed consistent seeding techniques. Nevertheless, based
upon the results of the individual growth factor experiments, and the apparent lack of
published studies describing TGF effects in bovine GCs, TGF was selected as the
growth factor of consequence for further study. In addition, there was evidence in the
literature at the time that TGF induces an upregulation of phosphorylated ERK1/2
expression in the granulosa-like, KGN cells [157]. We therefore hypothesized that TGF
has similar actions in bovine GCs, which warranted further testing.
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CHAPTER 3: EFFECTS OF TGF ON PROLIFERATION, MAPK/ERK SIGNALING
AND CYTOKINE-INDUCED APOPTOSIS IN BOVINE GRANULOSA CELLS
3.1 Introduction
Ovarian folliculogenesis is a dynamic process in which cohorts of follicles are
recruited and develop during selected periods of the estrous cycle [13], [14], [17], [158],
[159]. The process involves highly-coordinated and regulated interactions between the
systemic, pituitary-derived gonadotropins and their cellular targets at the ovarian level
(i.e., granulosa and theca cells and the oocytes). Cohorts of antral follicles emerge within
the ovary following an episodic surge in follicle stimulating hormone (FSH) [20]. These
follicles continue to grow and develop in synchrony due to proliferation of granulosa and
thecal cells and the development of the antrum [94], [160]. However, as the follicles
mature, a selection or deviation event occurs in which one follicle continues its growth to
become dominant, whereas the remaining follicles of the cohort become subordinate and
are vulnerable to atresia [73]. The dominant follicle then either ovulates or undergoes
atresia similar to its subordinates. Its fate depends upon on the phase of the estrous cycle
and the relative concentration of circulating progesterone [161]–[163]. The coordination
of the fates of these follicles is influenced by a vast array of autocrine and paracrine
regulators, including growth factors. In particular, growth factors are viewed as being
critical for selection of the dominant follicle and its deviation in growth from the
remaining follicles [33], [163].
There are a variety of growth factors within the ovary that not only stimulate the
growth of follicles, but also influence follicular fate (i.e., continued growth or atresia).
These include, insulin-like growth factor-1 (IGF-1; [101], [164]), epidermal growth
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factor (EGF; [44], [165], [166]), fibroblast growth factor (FBF; [132], [167]) and the
superfamily of transforming growth factor-beta (TGF; [168]). The cellular actions of
these growth factors are invoked principally through stimulation of multiple intracellular
signaling pathways, including receptor tyrosine kinase (RTK; [120], [169]), protein
kinase B (PI3K/Akt; [49], [170]), mitogen-activated protein kinase (MAPK/ERK; [26],
[27], [30]) and the Smad pathways ([173]). In recent years, oocyte-derived TGF
molecules, such as growth differentiation factors (GDF; [174], [175]) and bone
morphogenic proteins (BMP; [176], [177]) have attracted increased attention because of
their influence on granulosa cell (GC) and cumulus cell function, including proliferation,
steroidogenesis, differentiation, and apoptosis [177]–[179]. The concept that the oocyte
influences its own fate is particularly intriguing. However, TGF superfamily members
are not the only oocyte-derived factors that can influence follicular fate.
The EGF family of growth factors can also impact follicular fate by affecting GC
function [111]. Most notably, EGF family growth factors stimulate differentiation of GCs
and regulate steroidogenic function through the attenuation of GC production of estradiol
and inhibin, particularly in response to luteinizing hormone (LH) [111]. One such family
member, TGF, is a potent mitogen that stimulates cell growth through rapid activation
of MAPK/ERK and PI3K/Akt signaling [157]. Strong mitogens also likely promote GC
survival in the midst of follicular selection and deviation. EGF family members have
similar structure to one another, and bind to a common receptor (EGFR) to stimulate a
variety of ligand-specific cellular functions; including activation of RTK signaling, which
can simultaneously trigger both PI3K/Akt and MAPK/ERK pathways, and influence
cellular proliferation and differentiation [180]. EGFR ligands have diverse functions in
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multiple tissue types, and are particularly important factors involved in ovarian follicle
maturation and ovulation [118].
Stimulation of MAPK/ERK and PI3K/Akt signaling in GCs is particularly
important in oocyte-GC communications within the follicle. MAPK/ERK signaling is
activated by both follicle stimulating hormone (FSH) and LH stimulation in porcine GCs,
with LH stimulating the more rapid response [181]. In rat GCs, FSH activates
MAPK/ERK signaling and contributes to follicular growth and differentiation [182].
PI3K/Akt signaling promotes follicular survival through stimulation of cell proliferation,
transcription of FOXO3a (protecting cells from oxidative stress), and phosphorylation of
BAX (which prevents apoptosis) [170]. Phosphorylation of ERK and Akt in these
signaling pathways is higher in dominant follicles than subordinate follicles [171], and
their expression is upregulated in GCs of future dominant follicles before follicle
selection has occurred [108].
In the bovine ovary, TGF, which is known to stimulate both MAPK/ERK and
PI3K/Akt signaling [157], is expressed in both the oocyte and surrounding thecal cells
[44], [131]. It is thought to promote follicular growth through paracrine stimulation of
GC proliferation [45]. Thus, TGF and its actions through intracellular signaling may be
an important mechanism influencing follicular fate and the establishment of follicular
dominance. Effects of TGF on GC steroidogenesis is both stimulatory [183] and
inhibitory [134], but there is a general lack of knowledge about the direct effects of
TGF on bovine GC intracellular signaling and downstream effects like cytokineinduced apoptosis. In the current study, the objective was to evaluate these effects of
TGF on GCs obtained from bovine small (3-5mm) antral follicles. Cells were obtained
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from small follicles to ensure that a selection event had not yet occurred. TGF was
hypothesized to stimulate bovine GC proliferation and survival via a MAPK/ERKmediated mechanism.

3.2 Materials and Methods
3.2.1 Cell Culture and Reagents
Pairs of bovine ovaries were obtained from Champlain Beef (Whitehall, NY) and
transported to the laboratory in 0.9% NaCl solution supplemented with antibioticantimycotic at room temperature. All ovaries were collected and processed within 4-5
hours of slaughter. All small (3-5 mm) antral follicles were aspirated to obtain bovine
GCs. The GCs obtained from each ovary pair were kept separate, rather than pooled, for
the culture experiments. Hence, a given culture consisted of cells obtained from a single
pair of ovaries. The retrieved cells were pelleted, resuspended, and seeded into
independent T25 flasks. Cells were cultured in Dulbecco’s Modified Eagle
Medium/Ham’s F12 Nutrient Mixture (DMEM/F12) medium containing 10% FBS and
antibiotic-antimycotic (complete culture medium) and incubated in a humidified
incubator at 37C with 5% CO2 until the cultures reached confluency (~3-4 days). Once
confluent, the cells were passaged, enumerated, and subsequently seeded into culture
vessels for further testing. The day after seeding, the cultures were switched to serumfree DMEM/F12 medium supplemented with insulin-transferrin-selenium (ITS) (10ng/ml
insulin, 5.5ng/ml transferrin, 0.67pg/ml sodium selenite), without or with specific
concentrations of growth factor, cytokines, and/or inhibitors (see details below)
depending upon the experiment.
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3.2.2 Cell Treatment and Cell Proliferation
Bovine GCs were seeded into clear-walled, 96-well plates (5,000 cells/well) using
complete culture medium. The following day, the cells were switched to serum-free
medium containing recombinant human TGF (R&D Systems; 1, 10, or 100ng/mL) and
incubated for 24 hours. Following 24 hours of treatment, relative proliferation of bovine
GCs was assessed using an MTS assay (CellTiter 96 AQueous One Solution Cell
Proliferation Assay, Promega) in which the absorbance at 490 nm was measured and
recorded using a BioTek Synergy HT plate reader (BioTek).
3.2.3 Cell Treatment and Western Blot Analysis
Aliquots of bovine GCs were seeded in 6-well plates (150,000 cells/well) using
complete culture medium. The following day, the cells were serum-starved for 4 hours,
and then treated with recombinant human TGF (TGF)(R&D Systems; 10ng/mL) for 2
hours. MAPK inhibitor, U0126 (Millipore; 10M), was applied 1 hour prior to TGF
treatment. Following treatments, the cells were washed twice with ice-cold PBS solution
and lysed using RIPA buffer and scraping. The cell lysates were then transferred to
1.5mL tubes and passed through a 27-gauge needle. Protein concentration of each sample
was determined using the PierceTM BCA Protein Assay Kit (ThermoFisher). 10g of total
protein was loaded into the wells of a Mini-PROTEAN TGX Stain-Free Precast Gel
(BioRad) and separated using electrophoresis. Separated proteins were then transferred to
a PVDF membrane (BioRad) using a semi-dry transfer unit (Hoefer TE70XP), and the
resulting blot was blocked with TBST containing 5% BSA and then probed with primary
monoclonal antibodies for pERK1/2 (rabbit; cat# 4370) and ERK1/2 (mouse; cat# 4696).
Goat-anti-rabbit and rabbit-anti-mouse antibodies, respectively, conjugated with HRP
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were used in conjunction with Clarity Western ECL Substrate (BioRad) for imaging
using the BioRad ChemiDoc Imager. All antibodies were obtained from Cell Signaling
Technology. Immunoblots consisted of at least 3 biological replicates that were run either
in duplicate or triplicate.
3.2.4 Fas Ligand-induced Apoptosis
To evaluate the effects of TGF on the incidence of FasL-induced apoptosis, bovine GCs
were seeded either in 24-well plate (50,000 cells/well) or white-walled 96-well plates
(5,000 cells/well) in complete culture medium. The following day, the cells were
switched to serum-free medium containing either DMSO (0.1%), or U0126 (10M) and
incubated for 1 hour. Following inhibitor pre-treatment, growth factor treatments were
applied, and cells were incubated for an additional 24 hours. The growth factor tested was
TGF (100ng/mL). Dosing was based upon preliminary experiments (data not shown)
and dosing used in previous publications [157]. Following growth factor treatment,
recombinant human Fas Ligand (FasL) (EMD Millipore; 100ng/mL) was applied and the
incidence of apoptosis was determined visually (24-well plates – photographic images
taken at hour intervals for 8 hours) or by using a caspase assay (96-well plates - CaspaseGlo 3/7 Assay, Promega; detection run after 6 hours of FasL treatment). 6-hour FasL
treatment was determined through time-course observation of sufficient induction of cell
death and anticipated caspase activity before the administration of the Caspase Assay.
RLU values from the caspase assay were recorded using a BioTek Synergy HT plate
reader. Cells cultured in complete medium (i.e. 10% fetal bovine serum) throughout the
experimental period were used as the positive control to test for protection against
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cytokine-induced apoptosis. These experiments were conducted using 3-7 biological
replicates.
3.2.5 Statistical Analysis
All experiments were conducted using a minimum of three biological replicates
from an independent pair of ovaries (i.e., cow is the experimental unit). Data were
analyzed by analysis of variance (ANOVA), followed by a Student’s T-Test. Differences
among means were considered significant at p<0.05.
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3.3 Results
3.3.1 TGF stimulates bovine granulosa cell proliferation

Figure 3. MTS Assay analysis of bovine granulosa cell proliferation. Bars represent means of
recorded absorbance values at 490 nm  SEM (n = 7 ovary pairs) for bovine granulosa cells exposed
to different concentrations of TGF (0, 1, 10, or 100 ng/mL) for 24 hours. Different letters denote
differences in proliferation induced as a result of TGF treatments (p<0.05).

Dose-response experiments evaluating the effect of TGF on bovine GC
proliferation during a 24-hour culture indicated that cell numbers increased at the 10 and
100ng/mL doses (Figure 3). Conversely, TGF had no effect at the 1ng/mL dose. Based
on these observations, the higher doses of TGF were used in all subsequent
experiments.
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3.3.2 TGF effects in bovine granulosa cells occur via stimulation of MAPK/ERK
signaling

44 kDa
42 kDa

44 kDa
42 kDa

Figure 4. Immunoblot detection of pERK1/2 and ERK1/2 in bovine granulosa cells following
exposure to TGF (10 ng/mL) and/or MAPK inhibitor, U0126 (10 M). a.) Representative
immunoblot of pERK1/2 and ERK1/2 in response to treatments. b.) Bars representing mean
densitometry results of immunoblots  SEM (n = 3 ovary pairs). Relative expression is normalized to
total protein, and values have been transformed to represent fold change. Different letters denote
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differences in protein expression among the treatments (p<0.05). Treatment and inhibitor effects
were evaluated on relative protein expression quantified through the densitometry analysis. Data are
representative of 3 biological samples run in duplicate or triplicate.

MAPK signaling was stimulated in bovine GCs following TGF (10 ng/mL)
treatment, based upon the upregulation of phosphorylated ERK1/2 expression (Figure
4A). Densitometry analysis confirmed the upregulation to be 7-fold higher than that of
control samples (p<0.05; Figure 4B). This upregulation was attenuated, however, by the
MAPK inhibitor, U0126 (10M), which effectively reduced phosphorylated ERK1/2
expression to a level comparable to control (p<0.05; Figures 4A and B).
3.3.3 TGF fails to prevent Fas ligand-induced apoptosis of bovine granulosa cells

Figure 5. Representative images of bovine granulosa cells treated with FasL either with or without
TGFα (100 ng/mL). Cells were imaged on an hourly basis for 8 hours, images up to 6 hours are
shown. The presence of refractive and detached cells is indicative of cell death in response to FasL
(n = 3 ovary pairs).
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Figure 6. Caspase 3/7 activity assay analysis of bovine granulosa cells following 24-hour treatment
with TGFα (100 ng/mL), followed by a 6-hour exposure to FasL (100 ng/mL). The MAPK inhibitor,
U0126 (10 µM) or vehicle control, DMSO (0.01%) was applied to the cells 1 hour prior to TGFα
treatment. Treatment groups denoted with an asterisk (*) are different from the control group
(p<0.05). Bars having a different letter are statistically different (p<0.05; n = 7 ovary pairs).

24-hour pre-treatment of bGCs with TGF (100ng/mL) failed to provide any
protective effect against FasL-induced cell death (Figure 5). Signs of cell death in the
presence of FasL (i.e., refractive and detached cells in the culture) were observed as early
as 3 hours post-treatment (Figure 5.).. By 6 hours, most of the cells were dead or dying
and had become detached from the culture vessel (Figure 5). Comparatively, cells treated
with TGF had greater viability over the course of the culture period compared to cells in
serum-free control medium (Figure 5). In fact, the cells looked similar to those cultured
in FBS-containing, complete culture medium (images not shown). FasL-induced cell
death via apoptosis was evidenced by the increased expression of caspase 3/7 activity
(Figure 6). Interestingly, and unexpectedly, exposure of the cells to TGF enhanced
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susceptibility to FasL-induced apoptosis as compared to FasL alone (Figure 6); this effect
was observed regardless of MAPK inhibition (U0126), suggesting that TGFα-induced
MAPK stimulation provided no protection against FasL-induced apoptosis. Conversely,
FBS included in the culture medium abolished the FasL killing effect and protected
against the induction of apoptosis. (data not shown).
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CHAPTER 4: GENERAL DISCUSSION
In the work presented here bovine GCs were exposed to TGF to test the
hypothesis that TGF, through increases in MAPK/ERK signaling, provides resistance to
immune-mediated apoptosis. In so doing, it was determined that TGF stimulates a
proliferative response in bovine GCs and does this through activation of MAPK/ERK
signaling, as evidenced by an increase in the phosphorylation of ERK proteins. The use
of the MAPK inhibitor, U0126, showed the specificity of TGF-induced MAPK/ERK
signaling by completely abolishing the expression of phosphorylated ERK. In our serumfree culture system, it was also determined that Fas Ligand induces apoptosis of bovine
GCs, as evidenced by an increase in caspase 3/7 activity, and the effect is augmented by
prior exposure of the cells to TGF. Lastly, although TGF induced bovine GC
proliferation and stimulated MAPK/ERK signaling, there was no evidence to support the
hypothesis that MAPK/ERK signaling mediates a protective effect of TGFα on FasLinduced apoptosis. These observations collectively cast doubt on the likelihood that
TGFα, and MAPK/ERK signaling in particular, support granulosa cell survival and
follicular persistence during follicle selection and deviation.
A substantial amount literature exists in which effects of various intrafollicular
signaling molecules have been investigated. However, TGF has seemingly been
overshadowed by these and its better-known family member, EGF. Nevertheless, the
current study contributes to the existing literature and adds to our current understanding
of the molecular dynamics influencing ovarian physiology. For instance, results from the
current study support the concept of direct effects of TGF on bovine GCs, which
include stimulation of cell proliferation and the upregulation of MAPK/ERK signaling. In
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work of others, TGF induced a proliferative response in primary cultures of GCs from
cattle [131] and rats [184], as well as in immortalized GC lines [157], but the mechanistic
effects were not entirely elucidated. TGF induces proliferation of KGN cells (a
granulosa cell tumor line) through EGFR stimulation and activation of multiple
pathways, including mTOR, PI3K/Akt, and MAPK/ERK [157]. TGF is more potent
than EGF as a mitogen, but the effect are attributed to PI3K/Akt and mTOR, rather than
MAPK/ERK, activation [157]. Conversely, in current study, the proliferative effect of
TGF on bovine GCs appeared to be attributable to the stimulation of MAPK/ERK
signaling. The MAPK inhibitor, U0126, effectively negated TGF-induced effects on
ERK1/2 phosphorylation. In both the current and previous study [157], the TGFinduced phosphorylation of ERK occurred within 10 minutes of treatment and was
sustained for up to three days of culture. These observations suggest TGF is indeed a
potent activator of MAPK/ERK signaling, and lends credibility to the idea that
interactions between MAPK/ERK and PI3K/Akt signaling occur and promote cell
survival [185], [186].
The current results also support the previous findings of Glister and co-workers
[131], who demonstrated that TGF is expressed in bovine oocytes and stimulates GC
proliferation when co-cultured with oocytes [131]. GCs do not express TGF mRNA
[45], so there is no evidence that TGF is a GC-derived molecule. Beyond stimulating
GC proliferation, TGF also inhibits estradiol, inhibin, activin, and follistatin secretion
by GCs, but has no effect on progesterone production [131]. From these observations,
Glister and colleagues suggested a role for TGF in GC-oocyte interactions. However,
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as has become evident from the current study that the role of TGFα may be more
selective to the dominant follicle, particularly during ovulation and subsequent luteal
function, because TGFα fails to prevent FasL-induced apoptosis and most likely would
fail to protect against follicular atresia. The effects of TGF on bovine GC and theca
cells occur through EGFR stimulation [45]. Another growth factor, EGF, is also a potent
stimulator of GC proliferation [42]. Related molecules of the EGF family are expressed
and stimulate follicular growth in multiple species including chickens [187], goats [188],
pigs [124], and humans [189]. However, TGF is considered the major EGF ligand
within cow follicles [131], and may have a unique, mechanistic role in the follicle that
has yet to be characterized and understood.
Theca cells and/or oocytes are the principal sources of EGF and TGF secretion
in the ovary and possibly have paracrine effects on GCs through the EGFR [45], [165],
[190], [191]. In bovine GCs, the activation of both MAPK/ERK and PI3K/Akt signal
transduction promotes cell growth and viability, which is thought to translate to
development and differentiation of follicles [108]. Differences in the expression of
MAPK/ERK and PI3K/Akt proteins are evident between large and small follicles, but
more importantly, the difference in their expression occurs just after the emergence of the
“putative” dominant follicle [108]. Dominant follicles have higher expression of the
phosphorylated forms of ERK and Akt than subordinate follicles [171]. Elevated
expression of pERK and pAkt are detectable in the putative dominant follicle, and are
detectable before any other distinguishable markers, such as changes in follicular size or
estradiol production, become evident [108]. Thus, MAPK/ERK and PI3K/Akt signal
transduction may join forces to provide a selective advantage to follicles as they attain
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dominant status. In the current study, TGF clearly upregulated pERK expression in
bovine GCs, and we suggest that this effect occurs through MAPK/ERK activation.
Indeed, pERK expression is completely abolished by the MAPK inhibitor, U0126, which
confirms that the effects of TGF in bovine GC is mediated, at least in part, through the
MAPK/ERK pathway. Despite this, stimulation of MAPK/ERK signaling failed to
provide any protective effect against cell death in the FasL experiments. The lack of
protective effect was somewhat surprising because others report that a reduction in ERK
expression leads to apoptotic signaling [192]. In porcine GCs, for example, ERK
expression aids in cell survival during times of oxidative stress [172]. Although
considerable crossover exists between MAPK/ERK and PI3K/Akt signaling [185], [193],
and the expression of these two pathways differs between putative dominant and
subordinate bovine follicles [108], the question of which of these signaling mechanisms
ultimately impacts granulosa cell fate during follicle selection remains unresolved.
Perhaps the most compelling evidence, to date, to suggest that PI3K/Akt
signaling, rather than MAPK/ERK signaling, is most important to GC survival comes
from studies of IGF-1 effects. Briefly, Quirk and colleagues investigated the effects of
IGF-1 on FasL-induced apoptosis of GC in a variety of ways [105], [153], [194]. In
particular, IGF-1 exerts a protective effect against FasL-induced apoptosis in a manner
similar to fetal bovine serum (i.e., 10% FBS) [153]. Interestingly, EGF and basic FGF
(also found in FBS) also provide these effects, and EGF stimulates GC proliferation more
effectively than IGF-1 [153]. The protective effects occur through the activation of
PI3K/Akt signaling, and results in the inactivation of pro-apoptotic molecules, BAD and
caspase-9 [153]. However, others have found MAPK/ERK signaling has protective
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effects, coordinating extensively with PI3K/Akt signaling, by mediating cell survival
[185], reducing BAD expression [185], and preventing other apoptotic effects [110],
[172]. Use of IGF binding protein-3 (IGFBP-3) restores FasL-induced cell death in
serum-containing conditions [58], which suggests that IGF-1 alone in FBS-containing
culture medium is responsible for the protective effect. However, IGFBP-3 modulates not
only IGF-1-related signaling, but also the effects of TGF/Smad and EGFR signaling
[195], which further stimulate a variety of intracellular pathways. All of these factors,
including IGF-1, are likely components of FBS, so the conclusion that PI3/Akt activation
alone mediates cell survival is debatable. Of note, in most of the aforementioned
experiments, the culture medium often contained up to 5% FBS, and interferon gamma
was used to augment FasL-induced cell killing. In the current study, bovine GCs were
cultured using serum-free conditions, and FasL-induced apoptosis of bovine GCs in the
absence of interferon gamma. These precautions diminish the possibility that any
confounding growth factors, other than TGF alone, influenced the outcome of the FasL
experiments. Nevertheless, TGF failed to prevent FasL-induced apoptosis. Observing
that effects of TGF in bovine GCs are mediated, in part, through MAPK/ERK signaling,
the case for such signaling offering protection against cytokine-induced cell death is
weakened. Conversely, a compelling case can be made for the involvement of PI3K/Akt
signaling in GC survival during follicular selection in cattle [153], [196]. Furthermore,
inhibition of PI3K/Akt signaling stimulated by IGF-1 and TGF in chicken GCs results
in enhanced apoptosis, whereas inhibition of MAPK/ERK stimulation by these same
factors does not [197]. Although TGF induces phosphorylation of Akt, its actions are
less potent than IGF-1 [197], which further supports the concept of extensive crosstalk
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between MAPK/ERK and PI3K/Akt signaling in granulosa cells. Rather than influencing
follicular selection, perhaps TGF is more critical to differentiation of GCs within the
ovulatory follicle, augmenting the process of luteinization.
Based upon the results presented here and the findings of others [111], [131], we
now speculate that TGF is an oocyte-derived factor that induces MAPK/ERK signaling
in bovine GCs to prepare the dominant follicle for ovulation while simultaneously
preparing the oocyte for final maturation. In bovine GCs, EGF/TGF suppress estradiol
production [131], [134]. In humans, other EGF ligands (amphiregulin and epiregulin)
augment luteal steroidogenesis through activation of both ERK and Akt phosphorylation
[198]. Further evidence supporting this role of TGFα in GC differentiation stems from
work performed in human granulosa cells, wherein LH stimulated an upregulation of
mRNA and protein expression of EGF family members, amphiregulin and epiregulin, and
treatment with these factors, in turn, induced progesterone biosynthesis [198]. As the
follicle begins to prepare to ovulate, the cumulus GCs surrounding the oocyte undergo
rapid proliferation, with EGF stimulation of MAPK signaling being required for cumulus
expansion [199]. MAPK signaling is similarly important for oocyte maturation [200],
which clearly shows that connections between the oocyte and GC are mediated through
EGF ligands. The LH-induced breakdown of gap junctions between cumulus GC and the
oocyte triggers resumption of meiosis, and the activation of MAPK signaling is required
for this [200].
In conclusion, the results of the current study show that TGF is a potent
activator of bovine GC proliferation, in which the actions of TGFα are mediated
principally by MAPK/ERK signaling and the upregulation of phosphorylated ERK
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expression. Despite its growth-promoting properties, TGFα failed to prevent FasLinduced apoptosis, which casts doubt on its capacity to promote GC survival and follicle
persistence during bovine follicular selection and deviation. An alternative role for TGFα
is suggested, in which its actions via MAPK/ERK signaling facilitate differentiation of
GC within the follicle as ovulation becomes imminent.
Due to the eliminative culture methods utilized for the experiments herein, there
are a number of experimental pitfalls which could be addressed. One such pitfall being
that as more substances are removed from the culture media, the less likely the culture
environment mimics the in vivo conditions from which the cells are derived. Adding to
this, no phenotypic screening was pursued to confirm that the bovine granulosa cells in
culture had maintained their granulosa cell-like characteristics (e.g., the ability to respond
to FSH stimulation and produce estradiol). Because of this, the possibility remains that
the cells luteinized over the course of the culture period. Additionally, many of the
isolated growth factors utilized were of human origin. This problem of species-specificity
call into question whether human-derived biomolecules and growth factors exert the
same effects on bovine cells. It is conceivable that cow-derived growth factors with
different sequence homologies and binding specificities differ biologically from their
human isoforms. Any observed effects induced by the human-derived TGFα, for
example, might not exhibit an identical biological action to that of cow-derived TGFα.
Broader the impacts of this work could extend to feeding the world more
sustainably, and by understanding the reproductive mechanisms of cattle more clearly,
help to produce animal-sourced food in an economical manner. By improving our
understanding of bovine folliculogenesis at the cellular and molecular levels, estrus
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synchronization protocols may be further refined and applied in the context of improved
fertility in cattle. The United Nations Food and Agriculture Organization (FAO) predicts
that global food shortages will occur by 2050 as global human populations exceed the
rate of sustainable food production [201]. Many countries affected by population growth
have a growing middle class economy in which people earn more money and desire to
purchase animal-based food sources [202]. This presents a challenge to animal
agriculture, which has an ongoing goal to improve animal fertility in an efficient and
sustainable manner.
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